Modulation of Epidermal Growth Factor Receptor Status by Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer Is Rare | Zendy

Tommaso De Pas | Zendy; Giuseppe Pelosi | Zendy; Filippo de Braud | Zendy; Paolo Veronesi | Zendy; Giuseppe Curigliano | Zendy; Maria E. Leon | Zendy; Romano Danesi | Zendy; Cristioberasco | Zendy; Massimiliano D’Aiuto | Zendy; Gianpiero Catalano | Zendy; Giuseppe Viale | Zendy; Lorenzo Spaggiari | Zendy

Open Access

Modulation of Epidermal Growth Factor Receptor Status by Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer Is Rare

Author(s) -

Tommaso De Pas,

Giuseppe Pelosi,

Filippo de Braud,

Paolo Veronesi,

Giuseppe Curigliano,

Maria E. Leon,

Romano Danesi,

Cristioberasco,

Massimiliano D’Aiuto,

Gianpiero Catalano,

Giuseppe Viale,

Lorenzo Spaggiari

Publication year - 2004

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2004.01.195

Subject(s) - medicine , mediastinoscopy , chemotherapy , epidermal growth factor receptor , lung cancer , oncology , induction chemotherapy , stage (stratigraphy) , primary tumor , cancer , metastasis , paleontology , biology

To determine whether epidermal growth factor receptor (EGFR) expression in non-small-cell lung cancer (NSCLC) is modulated by chemotherapy and to assess the agreement of EGFR status between mediastinal nodes and the primary tumor after chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research